Utility of an objective dyskinesia rating scale for Parkinson's disease: Inter- and intrarater reliability assessment von Goetz, C. G., Stebbins, G. T., Shale, H. M., Lang, A. E., Chernik, D. A., Chmura, T. A., Ahlskog, J. E., Dorflinger, E. E.

Volltext

Tolcapone improves motor function in parkinsonian patients with the wearing-off phenomenon: A double-blind, placebo-controlled, multicenter trial von RAJPUT, A. H, MARTIN, W, SAINT-HILAIRE, M.-H, DORFLINGER, E, PEDDER, S

Volltext

P.3.e.009 Glycine reuptake inhibitor RG1678: results of the proof-of-concept study for the treatment of negative symptoms in schizophrenia von Umbricht, D, Martin-Facklam, M, Youssef, E, Yoo, K, Dorflinger, E, Bausch, A, Alberati, D, Santarelli, L

Volltext

Tolcapone in stable Parkinson's disease : Efficacy and safety of long-term treatment von WATERS, C. H, KURTH, M, BAILEY, P, SHULMAN, L. M, LEWITT, P, DORFLINGER, E, DEPTULA, D, PEDDER, S

Volltext

A pilot evaluation of the tolerability, safety, and efficacy of tolcapone alone and in combination with oral selegiline in untreated Parkinson's disease patients von Hauser, Robert A., Molho, Eric, Shale, Heidi, Pedder, Simon, Dorflinger, Ernest E.

Volltext

Tolcapone Improves Motor Function and Reduces Levodopa Requirement in Patients with Parkinson's Disease Experiencing Motor Fluctuations: A Multicenter, Double-Blind, Randomized, Pl... von Kurth, M. C., Adler, C. H., St. Hilaire, M., Singer, C., Waters, C., LeWitt, P., Chernik, D. A., Dorflinger, E. E., Yoo, K.

Volltext

Tolcapone improves motor function in parkinsonian patients with the "wearing-off" phenomenon: a double-blind, placebo-controlled, multicenter trial von Rajput, A H, Martin, W, Saint-Hilaire, M H, Dorflinger, E, Pedder, S

Volltext

Pharmacogenetic analysis of adverse drug effect reveals genetic variant for susceptibility to liver toxicity von ACUNA, Gonzalo, FOERNZLER, Dorothee, ZUNG TO, THOMPSON, Annick, JIA LI, HASHIMOTO, Lara, LINDPAINTNER, Klaus, LEONG, Diane, RABBIA, Michael, SMIT, Ralf, DORFLINGER, Ernest, GASSER, Rodolfo, HOH, Josephine, OTT, Jürg, BORRONI, Edilio

Volltext

Diffusion-Weighted MR Imaging of Intramedullary Spinal Cord Abscess von DÖRFLINGER-HEJLEK, E, KIRSCH, E. C, REITER, H, OPRAVIL, M, KAIM, A. H

Volltext

Slow recovery of human brain MAO B after L-Deprenyl (Selegeline) withdrawal von Fowler, Joanna S., Volkow, Nora D., Logan, Jean, Wang, Gene-Jack, Mac Gregor, Robert R., Schlyer, David, Wolf, Alfred P., Pappas, Naomi, Alexoff, David, Shea, Colleen, Dorflinger, Ernest, Kruchowy, Lesia, Yoo, Kisook, Fazzini, Enrico, Patlak, Clifford

Volltext

Illness impact and adjustment to Parkinson's disease: Before and after treatment with tolcapone von Welsh, Mickie D., Dorflinger, Ernest, Chernik, Doris, Waters, Cheryl

Volltext

Tolcapone added to levodopa in stable parkinsonian patients: A double-blind placebo-controlled study von Dupont, Erik, Burgunder, Jean-Marc, Findley, Leslie J., Olsson, Jan-Edvin, Dorflinger, Ernest

Volltext

Effect of lazabemide on the progression of disability in early Parkinson's disease von Kieburtz

Volltext

COMT inhibition and Parkinson's disease von Dorflinger, E., Magni, G., Hoffmann, F.

Volltext

Tolcapone in stable Parkinson's disease: Efficacy and safety of long-term treatment von Waters, C. H., Kurth, M., Bailey, P., Shulman, L. M., LeWitt, P., Dorflinger, E., Deptula, D., Pedder, S.

Volltext

A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease von Ostrowitzki, S, Lasser, RA, Dorflinger, E, Scheltens, P, Barkhof, F, Nikolcheva, T, Ashford, E, Retout, S, Hofmann, C, Delmar, P, Klein, G, Andjelkovic, M, Dubois, B, Boada, M, Blennow, K, Santarelli, L, Fontoura, P, SCarlet RoAD Investigators

Volltext bestellen

A pilot evaluation of the tolerability, safety, and efficacy of tolcapone alone and in combination with oral selegiline in untreated Parkinson's disease patients. Tolcapone De Novo... von Hauser, R A, Molho, E, Shale, H, Pedder, S, Dorflinger, E E

Volltext

Tolcapone improves motor function in parkinsonian patients with the wearing-off phenomenon : A double-blind, placebo-controlled, multicenter trial: Tolcapone: COMT inhibition for t... von RAJPUT, A. H, MARTIN, W, SAINT-HILAIRE, M.-H, DORFLINGER, E, PEDDER, S

Volltext

Tolcapone added to levodopa in stable parkinsonian patients: a double-blind placebo-controlled study. Tolcapone in Parkinson's Disease Study Group II (TIPS II) von Dupont, E, Burgunder, J M, Findley, L J, Olsson, J E, Dorflinger, E

Volltext

Tolcapone in stable Parkinson's disease: efficacy and safety of long-term treatment. Tolcapone Stable Study Group von Waters, C H, Kurth, M, Bailey, P, Shulman, L M, LeWitt, P, Dorflinger, E, Deptula, D, Pedder, S

Volltext